May News Roundup

Posted on May 31, 2019 — Jessica Jones Gupta

• May 10 – Leggy bots, flying bots, building bots: Here’s what Penn’s robotics hub is up to (Technical.ly Philly)
• May 13 –   For Philly Tech Week, a showcase for cutting-edge robots (Penn Today)
• May 19 –   ‘A better story’: PACT rally lauds top Philly biotech, software, boss and start-up talent (Philly.com)
• May 20 – Novartis CEO calls for new drug payment model ahead of Zolgensma launch (FiercePharma)
• May 24 – Newly Approved Spinal Muscle Atrophy Treatment Zolgensma is Based on Delivery System Discovered by Penn Gene Therapy Pioneer (Penn Medicine News)
• May 24- This New Treatment Could Save the Lives of Babies. But It Costs $2.1 Million. (New York Times)
• May 24 – At $2.1 million, newly approved Novartis gene therapy will be world’s most expensive drug (STAT)
• May 24 – The most expensive drug in the world (AXIOS)
• May 29 – Amicus, Penn expand gene therapy research agreement into five-year collaboration (Endpoint News)
• May 31 – Why 20,000 biotech fans from all over the world will flock to Philly next week (The Philadelphia Inquirer)

Category: news